These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10402028)
1. R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients. Müller T; Sällström Baum S; Häussermann P; Przuntek H; Rommelspacher H; Kuhn W J Neurol Sci; 1999 Apr; 164(2):158-62. PubMed ID: 10402028 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients. Müller T; Sällström Baum S; Häussermann P; Woitalla D; Rommelspacher H; Przuntek H; Kuhn W J Neural Transm (Vienna); 1998; 105(2-3):239-46. PubMed ID: 9660101 [TBL] [Abstract][Full Text] [Related]
3. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Naoi M; Maruyama W; Akao Y; Yi H Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189 [TBL] [Abstract][Full Text] [Related]
4. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease. Zhu W; Wang D; Zheng J; An Y; Wang Q; Zhang W; Jin L; Gao H; Lin L Clin Chem; 2008 Apr; 54(4):705-12. PubMed ID: 18238832 [TBL] [Abstract][Full Text] [Related]
5. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol. Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659 [TBL] [Abstract][Full Text] [Related]
6. [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients]. Krygowska-Wajs A; Szczudlik A; Antkiewicz-Michaluk L; Romańska I; Vetulani J Neurol Neurochir Pol; 1997; 31(5):875-85. PubMed ID: 9513952 [TBL] [Abstract][Full Text] [Related]
7. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease]. Maruyama W; Naoi M Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):333-42. PubMed ID: 11188501 [TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. Zhang W; Xie Y; Gu J; Ai S; Wang J; Yamamoto K; Jin L Analyst; 2004 Mar; 129(3):229-34. PubMed ID: 14978525 [TBL] [Abstract][Full Text] [Related]
9. Interrelationship between activation of dopaminergic pathways and cerebrospinal fluid concentration of dopamine tetrahydroisoquinoline metabolite salsolinol in humans: preliminary findings. Faraj BA; Camp VM; Kutner M Alcohol Clin Exp Res; 1991 Feb; 15(1):86-9. PubMed ID: 2024737 [TBL] [Abstract][Full Text] [Related]
10. Determination of (R)- and (S)-salsolinol sulfate and dopamine sulfate levels in plasma of nonalcoholics and alcoholics. Rommelspacher H; Sllström Baum S; Dufeu P; Schmidt LG Alcohol; 1995; 12(4):309-15. PubMed ID: 7546326 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective. Musshoff F; Lachenmeier DW; Kroener L; Schmidt P; Dettmeyer R; Madea B Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):837-49. PubMed ID: 14528920 [TBL] [Abstract][Full Text] [Related]
12. Cell death of dopamine neurons in aging and Parkinson's disease. Naoi M; Maruyama W Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535 [TBL] [Abstract][Full Text] [Related]
13. Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry. Musshoff F; Schmidt P; Dettmeyer R; Priemer F; Jachau K; Madea B Forensic Sci Int; 2000 Sep; 113(1-3):359-66. PubMed ID: 10978649 [TBL] [Abstract][Full Text] [Related]
14. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease. Maruyama W; Abe T; Tohgi H; Naoi M Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861 [TBL] [Abstract][Full Text] [Related]
16. Catecholamines and metabolites in cerebrospinal fluid of teetotallers and sober alcoholics. Sjöquist B; Borg S Drug Alcohol Depend; 1984 Jul; 13(4):389-94. PubMed ID: 6479017 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of salsolinol enantiomers and dopamine in human plasma and cerebrospinal fluid by chemical derivatization coupled to chiral liquid chromatography/electrospray ionization-tandem mass spectrometry. Lee J; Huang BX; Yuan Z; Kim HY Anal Chem; 2007 Dec; 79(23):9166-73. PubMed ID: 17973500 [TBL] [Abstract][Full Text] [Related]
18. Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. Musshoff F; Lachenmeier DW; Schmidt P; Dettmeyer R; Madea B Alcohol Clin Exp Res; 2005 Jan; 29(1):46-52. PubMed ID: 15654290 [TBL] [Abstract][Full Text] [Related]
19. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF. Moser A; Kömpf D Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074 [TBL] [Abstract][Full Text] [Related]
20. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]